The Journal of Experimental Medicine
VeriKine-HS Human Interferon-Beta Serum
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20090805
The Journal of Experimental Medicine, Vol. 206, No. 11, 2455-2467
The Rockefeller University Press, 0022-1007 $30.00
© Kunder et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 6455K)
Right arrow PDF+supp data (9219K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material
Right arrow Related biobytes podcast
Right arrow Related biobytes podcast
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Kunder, C. A.
Right arrow Articles by Abraham, S. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunder, C. A.
Right arrow Articles by Abraham, S. N.
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

 Mast cell–derived particles deliver peripheral signals to remote lymph nodes

Christian A. Kunder1, Ashley L. St. John2, Guojie Li1, Kam W. Leong3, Brent Berwin6, Herman F. Staats1,2,4, and Soman N. Abraham1,2,5,7

1 Department of Pathology, 2 Department of Immunology, 3 Department of Biomedical Engineering, 4 Department of Medicine, and 5 Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710
6 Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03755
7 Duke–National University of Singapore, Graduate Medical School, Singapore 169857

CORRESPONDENCE Soman N. Abraham: soman.abraham{at}duke.edu

During infection, signals from the periphery are known to reach draining lymph nodes (DLNs), but how these molecules, such as inflammatory cytokines, traverse the significant distances involved without dilution or degradation remains unclear. We show that peripheral mast cells, upon activation, release stable submicrometer heparin-based particles containing tumor necrosis factor and other proteins. These complexes enter lymphatic vessels and rapidly traffic to the DLNs. This physiological drug delivery system facilitates communication between peripheral sites of inflammation and remote secondary lymphoid tissues.

C.A. Kunder and A.L. St. John contributed equally to this paper.

Abbreviations used: BMMC, BM-derived MC; DLN, draining LN; HEV, high endothelial venule; MC, mast cell; SEM, scanning electron micrograph.

© 2009 Kunder et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Mast cells' message in a particle
Amy Maxmen
J. Exp. Med. 2009 206: 2304. [Full Text] [PDF]





  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS